These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 20123075)

  • 1. High-mobility group box 1 and cancer.
    Tang D; Kang R; Zeh HJ; Lotze MT
    Biochim Biophys Acta; 2010; 1799(1-2):131-40. PubMed ID: 20123075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical Role of High Mobility Group Box 1 in Glioma: A Suppressor or a Promoter?
    Seidu RA; Wu M; Su Z; Xu H
    Oncol Rev; 2017 Mar; 11(1):325. PubMed ID: 28382190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Masquerader: high mobility group box-1 and cancer.
    Ellerman JE; Brown CK; de Vera M; Zeh HJ; Billiar T; Rubartelli A; Lotze MT
    Clin Cancer Res; 2007 May; 13(10):2836-48. PubMed ID: 17504981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 in cancer: good, bad, or both?
    Kang R; Zhang Q; Zeh HJ; Lotze MT; Tang D
    Clin Cancer Res; 2013 Aug; 19(15):4046-57. PubMed ID: 23723299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy.
    Dong Xda E; Ito N; Lotze MT; Demarco RA; Popovic P; Shand SH; Watkins S; Winikoff S; Brown CK; Bartlett DL; Zeh HJ
    J Immunother; 2007 Sep; 30(6):596-606. PubMed ID: 17667523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
    Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
    Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W
    Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function.
    Müller S; Ronfani L; Bianchi ME
    J Intern Med; 2004 Mar; 255(3):332-43. PubMed ID: 14871457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGB1 in inflammation and cancer.
    Wang S; Zhang Y
    J Hematol Oncol; 2020 Aug; 13(1):116. PubMed ID: 32831115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high mobility group box 1 in innate immunity.
    Lee SA; Kwak MS; Kim S; Shin JS
    Yonsei Med J; 2014 Sep; 55(5):1165-76. PubMed ID: 25048472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB and cancer-identifying targets and mechanisms.
    Naugler WE; Karin M
    Curr Opin Genet Dev; 2008 Feb; 18(1):19-26. PubMed ID: 18440219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MIR155 host gene/microRNA-627/HMGB1/NF-κB loop modulates fibroblast proliferation and extracellular matrix deposition.
    Li J; Zhang X; Wang T; Li J; Su Q; Zhong C; Chen Z; Liang Y
    Life Sci; 2021 Mar; 269():119085. PubMed ID: 33482190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct molecular interactions between HMGB1 and TP53 in colorectal cancer.
    Livesey KM; Kang R; Zeh HJ; Lotze MT; Tang D
    Autophagy; 2012 May; 8(5):846-8. PubMed ID: 22647615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease.
    Lohani N; Rajeswari MR
    Curr Protein Pept Sci; 2016; 17(8):762-775. PubMed ID: 26916160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.
    Huang Z; Zhong Z; Zhang L; Wang X; Xu R; Zhu L; Wang Z; Hu S; Zhao X
    Sci Rep; 2015 Aug; 5():12807. PubMed ID: 26239046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.
    Kang R; Xie Y; Zhang Q; Hou W; Jiang Q; Zhu S; Liu J; Zeng D; Wang H; Bartlett DL; Billiar TR; Zeh HJ; Lotze MT; Tang D
    Cell Res; 2017 Jul; 27(7):916-932. PubMed ID: 28374746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HMGB1--its role in tumor progression and anticancer therapy].
    Smolarczyk R; Cichoń T; Jarosz M; Szala S
    Postepy Hig Med Dosw (Online); 2012 Nov; 66():913-20. PubMed ID: 23175347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.
    Yang H; Wang H; Chavan SS; Andersson U
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S6-S12. PubMed ID: 26605648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous HMGB1 regulates autophagy.
    Tang D; Kang R; Livesey KM; Cheh CW; Farkas A; Loughran P; Hoppe G; Bianchi ME; Tracey KJ; Zeh HJ; Lotze MT
    J Cell Biol; 2010 Sep; 190(5):881-92. PubMed ID: 20819940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.